This activity was reviewed on July 25, 2018.
12.75 / AMA PRA Category I Credit(s)TM
This course is jointly provided by Haymarket Medical Education (HME) and WebCME.
This course offers physicians, mid-level practitioners, and allied health care professionals a comprehensive review of the major clinical and operational knowledge domains related to the practice of hyperbaric medicine, including oxygen physiology, and the physics and mechanisms-of-action for hyperbaric oxygen therapy (HBOT). Lectures include a review of the primary clinical indications for treatment, management of the patient undergoing hyperbaric therapy, and principal operational aspects of the hyperbaric facility. While focused on ensuring success in passing any of the currently offered certification exams, this course is also an excellent educational opportunity for all health care professionals who want to expand their knowledge of HBOT.
This course has been designed to meet the educational needs of physicians, mid-level practitioners, and allied health care professionals involved in treating patients in need of hyperbaric clinical applications. This course is appropriate for physicians, mid-level practitioners, and supporting health care practitioners who seek an in-depth review of major clinical and operational areas related to the practice of hyperbaric medicine.
Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest in an effort to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, HME seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. HME is committed to providing its learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be related to the content of this CME activity:
Jeffrey A. Niezgoda, MD, FACHM, MAPWCA, CHWS
President & Chief Medical Officer
West Allis, WI
Jeffrey A. Niezgoda, MD, FACHM, MAPWCA, CHWS (Course Director) has indicated no relevant financial disclosures.
Thomas E. Serena, MD, FACS, FACHM
Founder and Medical Director
Penn North Centers for Advanced Wound Care
Thomas E. Serena, MD, FACS, FACHM, has received research funds from Andover, Acelity, Systagenix, BSN, Med Compliances IQ, Medline, MTF, MiMedix, Novartis, Organogenesis, RedDress, and TR Therapeutics. Dr. Serena also received consulting fees for Acelity, Med Compliances IQ, Medline, Mego Aflec/Lympha Press USA, MiMedix, RedDress, and WoundCheck Labs. Dr. Serena is on the Speakers' Bureaus for Acelity and Osiris.
Tyler Sexton, MD, CHWS, CHT, DMT
Caribbean Hyperbaric Medicine
Tyler Sexton, MD, CHWS, CHT, DMT, has indicated no relevant financial disclosures.
The planners and managers at Haymarket Medical Education and WebCME reported that they have no relevant financial relationships with commercial interests whose products or services may be related to the content of this CME activity.